A Targeted Intervention To Improve Awareness To Molecular Testing In Nsclc.

6547 Background: Molecular testing is now standard of care to guide treatment selection in advanced NSCLC. Population-based implementation of testing remains a challenge in Ontario’spublic healthcare system, with ~37% of eligible samples undergoing testing and~12% insufficient for testing. We developed an intervention to improve understanding among Ontario specialists of the importance of molecular testing and appropriate diagnostic sampling in NSCLC. Methods: Based on IASLC guidelines for molecular testing in NSCLC, leaders in lung pathology, respirology, interventional radiology and thoracic surgery identified key messages for each specialty regarding molecular testing and diagnostic sampling in lung cancer. Specialty-specific educational programs (delivered by a multidisciplinary team) were developed and administered at provincial and national specialty meetings. Participants were assessed on their knowledge of targeted therapy, molecular testing and sample requirements Results: Ten educational program...